Year archive

Oramed Pharmaceuticals Inc. — 2024 filings

All 124 regulatory filings released by Oramed Pharmaceuticals Inc. (ORMP) in 2024, sourced directly from the official regulator.

124 Filings

2024 Period

2024 filings (124)

Filing	Released	Lang
reception of an additional payment from Scilex Holding Company Regulatory Filings	2024-12-18	English
reception of an additional payment from Scilex Holding Company Report Publication Announcement	2024-12-18	English
CURRENT REPORT Regulatory Filings	2024-12-17	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-HEXTER JOSHUA Director's Dealing	2024-11-10	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-HEXTER JOSHUA Director's Dealing	2024-11-10	English
INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTSAS OF SEPTEMBER 30, 2024 Interim / Quarterly Report 9M 2024	2024-11-10	English
INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTSAS OF SEPTEMBER 30, 2024 Report Publication Announcement FY 2024	2024-11-10	English
Director's Dealing 2024 Director's Dealing	2024-11-08	English
Director's Dealing 2024 Director's Dealing	2024-11-08	English
Director's Dealing 2024 Director's Dealing	2024-11-08	English
Director's Dealing 2024 Director's Dealing	2024-11-08	English
QUARTERLY REPORT Interim / Quarterly Report Q3 2024	2024-11-07	English
An additional payment was received due to an agreement with Silex Capital/Financing Update	2024-10-30	English
An additional payment was received due to an agreement with Silex Regulatory Filings	2024-10-30	English
CURRENT REPORT Regulatory Filings	2024-10-29	English
Refinancing Agreement between Oramed and Scilex Regulatory Filings	2024-10-09	Hebrew (modern)
Refinancing Agreement between Oramed and Scilex Report Publication Announcement	2024-10-09	English
CURRENT REPORT Regulatory Filings	2024-10-08	English
CURRENT REPORT Regulatory Filings	2024-09-26	English
CURRENT REPORT Regulatory Filings	2024-09-23	English
Major Shareholding Notification 2024 Major Shareholding Notification	2024-09-16	English
Form 10Q - 30.06.2024 Interim / Quarterly Report Q2 2024	2024-08-15	English
Form 10Q - 30.06.2024 Report Publication Announcement	2024-08-15	English
QUARTERLY REPORT Interim / Quarterly Report Q2 2024	2024-08-14	English
CURRENT REPORT Regulatory Filings	2024-08-02	English
The Company’s Board of Directors authorized a stock buyback program to purchase up to $20,000,000 Transaction in Own Shares	2024-06-26	English
The Company’s Board of Directors authorized a stock buyback program to purchase up to $20,000,000 Regulatory Filings	2024-06-26	English
CURRENT REPORT Regulatory Filings	2024-06-26	English
Received an additional payment from Scilex Regulatory Filings	2024-06-24	English
Received an additional payment from Scilex Regulatory Filings	2024-06-24	English
CURRENT REPORT Regulatory Filings	2024-06-24	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Gabay Avraham Director's Dealing	2024-06-22	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Gabay Avraham Director's Dealing	2024-06-22	English
FORM 4-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Gabay Avraham Director's Dealing	2024-06-22	English
FORM 4-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Gabay Avraham Director's Dealing	2024-06-22	English
Director's Dealing 2024 Director's Dealing	2024-06-21	English
Director's Dealing 2024 Director's Dealing	2024-06-21	English
ORAMED PHARMACEUTICALS INC. 2023 ANNUAL REPORT Annual Report FY 2023	2024-06-20	English
ORAMED PHARMACEUTICALS INC. 2023 ANNUAL REPORT Audit Report / Information FY 2024	2024-06-20	English
PROXY STATEMENT OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON AUGUST 1, 2024 Proxy Solicitation & Information Statement	2024-06-20	English
PROXY STATEMENT OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON AUGUST 1, 2024 Proxy Solicitation & Information Statement	2024-06-20	English
FORM ARS Annual Report	2024-06-20	English
DEFINITIVE PROXY STATEMENT Proxy Solicitation & Information Statement	2024-06-20	English
Appointment of Mr. Avraham Gabay to serve as the Chief Financial Officer Board/Management Information	2024-06-10	English
Appointment of Mr. Avraham Gabay to serve as the Chief Financial Officer Report Publication Announcement	2024-06-10	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Reznick Yehuda Director's Dealing	2024-06-10	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Reznick Yehuda Director's Dealing	2024-06-10	English
CURRENT REPORT Regulatory Filings	2024-06-10	English
Director's Dealing 2024 Director's Dealing	2024-06-10	English
Resigned from positions ,the Chief Financial Officer-David Silberman Board/Management Information	2024-05-13	English
Resigned from positions ,the Chief Financial Officer-David Silberman Report Publication Announcement	2024-05-13	English
CURRENT REPORT Regulatory Filings	2024-05-10	English
Form 10-Q-For the quarterly period ended March 31, 2024 Interim / Quarterly Report Q1 2024	2024-05-09	English
Form 10-Q-For the quarterly period ended March 31, 2024 Report Publication Announcement	2024-05-09	English
QUARTERLY REPORT Interim / Quarterly Report Q1 2024	2024-05-09	English
Update on the receipt of payments for the Scilex transaction Regulatory Filings	2024-05-06	English
Update on the receipt of payments for the Scilex transaction Report Publication Announcement	2024-05-06	English
CURRENT REPORT Regulatory Filings	2024-05-06	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Reznick Yehuda Director's Dealing	2024-04-19	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Reznick Yehuda Director's Dealing	2024-04-19	English
Director's Dealing 2024 Director's Dealing	2024-04-18	English
FORM 3- INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OFSECURITIES-Reznick Yehuda Director's Dealing	2024-04-03	English
FORM 3- INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OFSECURITIES-Reznick Yehuda Director's Dealing	2024-04-03	English
Director's Dealing 2024 Director's Dealing	2024-04-02	English
13D-Nadav Kidron Major Shareholding Notification	2024-03-26	English
13D-Nadav Kidron Report Publication Announcement	2024-03-26	English
SCHEDULE 13D Major Shareholding Notification	2024-03-22	English
Update on the receipt of payments for the Scilex transaction Capital/Financing Update	2024-03-19	English
Update on the receipt of payments for the Scilex transaction Regulatory Filings	2024-03-19	English
CURRENT REPORT Regulatory Filings	2024-03-19	English
Appointed Mr. Yehuda Reznick to serve as a director Board/Management Information	2024-03-18	English
Appointed Mr. Yehuda Reznick to serve as a director Report Publication Announcement	2024-03-18	English
entered into ATM Agreemen with Agents having maximum aggregate offering price up to 75,000,000$ Regulatory Filings	2024-03-18	English
entered into ATM Agreemen with Agents having maximum aggregate offering price up to 75,000,000$ Regulatory Filings	2024-03-18	English
Form 424b5-AT THE MARKET AGREEMENT Up to $75,000,000 COMMON STOCK Capital/Financing Update	2024-03-18	English
Form 424b5-AT THE MARKET AGREEMENT Up to $75,000,000 COMMON STOCK Regulatory Filings	2024-03-18	English
CURRENT REPORT Regulatory Filings	2024-03-18	English
CURRENT REPORT Regulatory Filings	2024-03-18	English
PROSPECTUS SUPPLEMENT Prospectus	2024-03-18	English
10K: Annual Report For the Fiscal Year Ended December 31, 2023 Annual Report FY 2023	2024-03-06	English
10K: Annual Report For the Fiscal Year Ended December 31, 2023 Report Publication Announcement FY 2023	2024-03-06	English
ANNUAL REPORT Annual Report FY 2023	2024-03-06	English
Form 8-K - CEO Letter Regulatory Filings	2024-02-20	English
Form 8-K - CEO Letter Report Publication Announcement	2024-02-20	English
CURRENT REPORT Regulatory Filings	2024-02-20	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Aghion Daniel Director's Dealing	2024-01-30	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Aghion Daniel Report Publication Announcement	2024-01-30	English
FORM 4 SUBMISSION Director's Dealing	2024-01-30	English
JOINT VENTURE AGREEMENT Regulatory Filings	2024-01-23	English
JOINT VENTURE AGREEMENT Report Publication Announcement	2024-01-23	English
CURRENT REPORT Regulatory Filings	2024-01-23	English
FORM 8-K -Yadin Rozov resignation from the Board Board/Management Information	2024-01-20	English
FORM 8-K -Yadin Rozov resignation from the Board Board/Management Information	2024-01-20	English
CURRENT REPORT Regulatory Filings	2024-01-19	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Rozov Yadin Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Rozov Yadin Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Nadav Kidron Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Nadav Kidron Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Miriam Kidron Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Miriam Kidron Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Leonard Sank Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Leonard Sank Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Joshua Hexter Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Joshua Hexter Director's Dealing	2024-01-08	English
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Daniel Aghion Director's Dealing	2024-01-08	English
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Daniel Aghion Director's Dealing	2024-01-08	English
CHANGES IN BENEFICIAL OWNERSHIP-FORM 4-Benjamin Shapiro Director's Dealing	2024-01-08	English
CHANGES IN BENEFICIAL OWNERSHIP-FORM 4-Benjamin Shapiro Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- David Silberman Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- David Silberman Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Arie Mayer Director's Dealing	2024-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Arie Mayer Director's Dealing	2024-01-08	English
FORM 4 SUBMISSION Director's Dealing	2024-01-08	English
FORM 4 SUBMISSION Director's Dealing	2024-01-08	English
FORM 4 SUBMISSION Director's Dealing	2024-01-08	English
FORM 4 SUBMISSION Director's Dealing	2024-01-08	English
FORM 4 SUBMISSION Director's Dealing	2024-01-08	English
FORM 4 SUBMISSION Director's Dealing	2024-01-08	English
FORM 4 SUBMISSION Director's Dealing	2024-01-08	English
FORM 4 SUBMISSION Director's Dealing	2024-01-08	English
FORM 4 SUBMISSION Director's Dealing	2024-01-08	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Aghion Daniel Director's Dealing	2024-01-02	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Aghion Daniel Director's Dealing	2024-01-02	English
FORM 3 SUBMISSION Director's Dealing	2024-01-02	English

Filings by year

2026 32 filings
2025 80 filings
2024 124 filings
2023 114 filings
2022 131 filings
2021 172 filings
2020 112 filings
2019 133 filings
2018 85 filings
2017 96 filings
2016 32 filings
2015 38 filings
2014 64 filings
2013 54 filings
2012 62 filings
2011 43 filings
2010 44 filings
2009 27 filings
2008 40 filings
2007 31 filings
2006 20 filings
2005 19 filings
2004 14 filings
2003 7 filings
2002 1 filing